Novel biomarkers in mutation-specific gene profiles highlight the involvement of COL9A3 in cancer cell plasticity in uveal melanoma
Q.C.C. van den Bosch, R. M. Verdijk, H. Fadlelseed, Thierry P. P. van den Bosch, S. Owens, Susan Kennedy, E. Kilic, E. Brosens
The paper identifies COL9A3 as a novel high-risk biomarker in uveal melanoma associated with cell plasticity and is most prevalent in BAP1mut tumors.
bioRxiv · Apr 24, 2025 · PreprintCancer Biology